Bioinformatory‐assisted analysis of next‐generation sequencing data for precision medicine in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is a tumor with an extremely poor prognosis, predominantly as a result of chemotherapy resistance and numerous somatic mutations. Consequently, PDAC is a prime candidate for the use of sequencing to identify causative mutations, facilitating subsequent adminis...

Descripción completa

Detalles Bibliográficos
Autores principales: Malgerud, Linnéa, Lindberg, Johan, Wirta, Valtteri, Gustafsson‐Liljefors, Maria, Karimi, Masoud, Moro, Carlos Fernández, Stecker, Katrin, Picker, Alexander, Huelsewig, Carolin, Stein, Martin, Bohnert, Regina, Del Chiaro, Marco, Haas, Stephan L., Heuchel, Rainer L., Permert, Johan, Maeurer, Markus J., Brock, Stephan, Verbeke, Caroline S., Engstrand, Lars, Jackson, David B., Grönberg, Henrik, Löhr, Johannes‐Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623817/
https://www.ncbi.nlm.nih.gov/pubmed/28675654
http://dx.doi.org/10.1002/1878-0261.12108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623817/
https://www.ncbi.nlm.nih.gov/pubmed/28675654
http://dx.doi.org/10.1002/1878-0261.12108

Ejemplares similares